Jennison Associates
KYTH

Jennison Associates’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Jennison Associates’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,589,903
Closed -$119M – 781
2015
Q3 		$119M Sell
1,589,903
-594,104
-27% -$44.4M 0.12% 150
2015
Q2 		$164M Buy
2,184,007
+23,569
+1% +$1.26M 0.15% 118
2015
Q1 		$108M Buy
2,160,438
+528,269
+32% +$22.2M 0.1% 194
2014
Q4 		$56.6M Sell
1,632,169
-238,483
-13% -$8.32M 0.05% 304
2014
Q3 		$61.3M Sell
1,870,652
-24,251
-1% -$854K 0.06% 300
2014
Q2 		$72.7M Buy
1,894,903
+367,130
+24% +$12.8M 0.07% 263
2014
Q1 		$60.7M Buy
1,527,773
+89,158
+6% +$3.99M 0.06% 293
2013
Q4 		$53.6M Buy
1,438,615
+259,364
+22% +$10.8M 0.05% 292
2013
Q3 		$53.9M Sell
1,179,251
-11,446
-1% -$342K 0.06% 287
2013
Q2 		$32.2M Buy
+1,190,697
New +$27.2M 0.04% 361

Jennison Associates's KYTH Position: Q4 2015 in Review

Jennison Associates sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 1,589,903 shares — an estimated $119M sold.

Jennison Associates first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $164M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Jennison Associates reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Jennison Associates sold 1,589,903 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $119M.
  • Jennison Associates first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Jennison Associates's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $164M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Jennison Associates's 13F filing for Q4 2015, filed 10 Feb 2016.